CMS certification 050291
Sutter Santa Rosa Regional Hospital
30 Mark West Springs Road, Santa Rosa, CA 95403
Sutter Santa Rosa Regional Hospital has a CMS overall rating of 5 out of 5 stars. 79% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. Emergency patients spend a median of 3 h 32 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 752 completed surveys, 22% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | CA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 378 visits sampled · US median for EDs of the same volume: 3 h 22 min | 3 h 32 min | 2 h 54 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 20 visits sampled | 5 h 2 min | 4 h 20 min | 4 h 17 min |
| Left before being seen Lower is better · 45,020 patients | 2% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 17 patients | 76% | 74% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 146 patients | 63% | 70% | 65% |
How Sutter Santa Rosa Regional Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Sutter Santa Rosa Regional HospitalThis hospital | 5/5 | 79% | 3 h 32 min | 3 better 1 worse |
| Kaiser Foundation Hospital-Santa RosaSame city | 3/5 | 75% | — | 2 better |
| Providence Santa Rosa Memorial HospitalSame city | 3/5 | 69% | 2 h 43 min | 2 better 1 worse |
| Healdsburg HospitalSame county · Healdsburg | Not rated | 77% | 1 h 34 min | 1 worse |
| Sonoma Valley HospitalSame county · Sonoma | 2/5 | 79% | 1 h 59 min | No different |
| Petaluma Valley HospitalSame county · Petaluma | 4/5 | 70% | 2 h 50 min | 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Santa Rosa.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,971 cases | Too few cases | 2.9% | 3.9% |
| Heart attack 192 cases | Too few cases | 11.8% | 11.9% |
| Heart failure 316 cases | Too few cases | 10.5% | 11.1% |
| Pneumonia 296 cases | Too few cases | 14% | 15.2% |
| Stroke 142 cases | Too few cases | 11.6% | 11.9% |
| COPD 85 cases | Too few cases | 6.8% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.03 likely 0.69 – 1.37 | 1 |
| After hip or knee replacement 206 cases | Too few cases | 3.1% | 4.1% |
| Deaths after a serious but treatable surgical complication 54 cases | No different | 162.53 per 1,000 likely 108.3 per 1,000 – 216.76 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,064 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.89 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,946 cases | No different | 0.26 per 1,000 likely 0.06 per 1,000 – 0.47 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 4,974 cases | No different | 0.23 per 1,000 likely 0.03 per 1,000 – 0.43 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,214 cases | No different | 2.36 per 1,000 likely 0.82 per 1,000 – 3.9 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 532 cases | No different | 1.5 per 1,000 likely 0 per 1,000 – 3.15 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 558 cases | No different | 9.87 per 1,000 likely 2.35 per 1,000 – 17.39 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,288 cases | No different | 4.99 per 1,000 likely 2.93 per 1,000 – 7.06 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 522 cases | No different | 8.01 per 1,000 likely 4.29 per 1,000 – 11.73 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 337 cases | No different | 1.6 per 1,000 likely 0.14 per 1,000 – 3.05 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,147 cases | No different | 1.03 per 1,000 likely 0.08 per 1,000 – 1.99 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.63 likely 0.16 – 1.71 | 1 |
| Surgical site infections after colon surgery | No different | 0 | 1 |
| MRSA bloodstream infections | No different | 0.3 likely 0.02 – 1.47 | 1 |
| C. diff intestinal infections | Better | 0.16 likely 0.07 – 0.31 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 186 cases | Too few cases | 14.1% | 14.4% |
| Readmitted after heart failure 342 cases | Too few cases | 21% | 21.3% |
| Readmitted after pneumonia 309 cases | Too few cases | 16.2% | 17.3% |
| Readmitted after COPD 100 cases | Too few cases | 19.8% | 20% |
| Readmitted after hip or knee replacement 215 cases | Too few cases | 5.3% | 5.8% |
| Days back in hospital after a heart attack 184 cases | Too few cases | -4.1 days per 100 | — |
| Days back in hospital after heart failure 352 cases | Too few cases | -14 days per 100 | — |
| Days back in hospital after pneumonia 309 cases | Too few cases | -17.4 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,275 cases | No different | 14 per 1,000 likely 10.8 per 1,000 – 18 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 259 cases | No different | 11.6 per 100 likely 8.8 per 100 – 15 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 259 cases | No different | 7.2 per 100 likely 5.1 per 100 – 9.8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 702 cases | No different | 1.1 likely 0.9 – 1.4 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
45 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 12 |
| Hospitalist | 5 |
| Family | 3 |
| Family Medicine | 3 |
| Acute Care | 2 |
| Anesthesiology | 2 |
| Clinical | 2 |
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist | 2 |
| Pharmacotherapy | 2 |
| Colon & Rectal Surgery | 1 |
| Critical Care Medicine | 1 |
| Diagnostic Radiology | 1 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $197,938
- 2020 $270,033
- 2021 $62,514
- 2022 $60,063
- 2023 $478,008
- 2024 $194,950
- 2025 $556,210
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $5,000 | 2 |
| Gifts | $750 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $307,498 | 4 |
| Janssen Research & Development, LLC | $184,476 | 42 |
| Abbvie INC. | $40,005 | 3 |
| AstraZeneca UK Limited | $17,100 | 1 |
| Incyte Corporation | $3,882 | 2 |
| Janssen Biotech, Inc. | $2,500 | 1 |
| Alexion Pharmaceuticals, Inc. | $750 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patient… AstraZeneca Pharmaceuticals LP | $203,745 |
| A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK) Janssen Research & Development, LLC | $171,976 |
| A Two Part Phase IIa b Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-ranging Study to Assess Efficacy, Safety, and T… AstraZeneca Pharmaceuticals LP | $91,047 |
| M20-621 - A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-C… ABBVIE INC. | $24,952 |
| A Phase III Double-Blind Randomised Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel… AstraZeneca UK Limited | $17,100 |
| A Phase 3 Multicenter Randomized Open-Label Trial to Evaluate Safety and Efficacy of Epcoritamab in Combination with R-CHOP compared to R-CHOP in Sub… ABBVIE INC. · NCT05578976 | $15,053 |
| A Phase 3 Randomized Study Comparing Teclistamab Monotherapy versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) … Janssen Research & Development, LLC | $12,500 |
| Dapagliflozin in Acute Decompensated Heart Failure AstraZeneca Pharmaceuticals LP | $10,206 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Sutter Santa Rosa Regional Hospital
Is Sutter Santa Rosa Regional Hospital a good hospital?
Sutter Santa Rosa Regional Hospital has a CMS overall rating of 5 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Sutter Santa Rosa Regional Hospital?
79% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 752 completed HCAHPS surveys.
How long is the wait in the Sutter Santa Rosa Regional Hospital emergency room?
Emergency patients spend a median of 3 h 32 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Sutter Santa Rosa Regional Hospital receive money from drug and device companies?
Drug and device makers reported $556,210 in payments to Sutter Santa Rosa Regional Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.